2018 AVBCC Summit

AVBCC

October 30-31, 2018 | New York Athletic Club, New York, NY

The Association for Value-Based Cancer Care (AVBCC) invites you to attend the 2018 AVBCC Summit in New York, NY on October 30-31, 2018. This is a prime opportunity to gain a thorough understanding of the evolution of the value equation as it relates to cancer therapies and discover how to implement, improve, and sustain your company or institution, while improving access for patients and ultimately patient care.

Top 3 Reasons to Attend the 2018 AVBCC Conference

  • Stay competitive in the ever-changing field of oncology participating in sessions on topics including Health Policy, Telemedicine, Practice Management, Oncology Specialty Pharmacy and Supply Chain, and more.
  • Learn from stakeholders within the cancer care spectrum, including practitioners, pharmacists, payers, and policymakers to improve patient care and maximize patient access and outcomes through care coordination.
  • Network with nationally recognized experts, faculty speakers, panelists, key opinion leaders, C-suite executives, and managers to exchange best practices in advanced value-based performance and quality measures in cancer care.
No other meeting brings together so many key perspectives in cancer care.

Invited Faculty


    • Edward Abrahams, PhD
    • President
    • Personalized Medicine Coalition
    • Cheryl Allen, BS, PharmD, MBA
    • Vice President, Industry Relations
    • Diplomat Specialty Pharmacy
    • Rachel Anhorn, PharmD
    • Director, Payer Policy & Health Outcomes
    • Foundation Medicine
    • Sheila Arquette, RPh
    • Executive Director
    • National Association of Specialty Pharmacy
    • Peter Bach, MD
    • Director, Center for Health Policy & Outcomes
    • Memorial Sloan Kettering Cancer Center
    • Ray Bailey, RPh, BPharm
    • Pharmacy Director
    • Florida Cancer Specialists
    • Al Benson III, MD, FACP, FASCO
    • Associate Director, Clinical Investigations
    • Lurie Comprehensive Cancer Center
    • Northwestern University
    • Kim Blackwell, MD
    • VP, Early Phase Development &
    • Immuno-oncology
    • Eli Lilly and Company
    • Douglas Bock, MBA
    • Partner
    • Archbow Consulting
    • Brian Bourbeau, MBA
    • Associate Director, Business Metrics & Analysis American Society of Clinical Oncology
    • Michael Bracchi
    • VP, Pharmacy Services
    • Cancer Treatment Centers of America
    • Joel Brill, MD
    • Chief Medical Officer
    • Predictive Health, LLC
    • Barry Brooks, MD
    • Chairman, Contracting Subcommittee
    • US Oncology Network
    • Danielle Bubnis
    • Senior Director, Advocacy
    • Leukemia & Lymphoma Society
    • Eric Dozier, BS, MBA
    • VP, North American Oncology
    • Eli Lilly and Company
    • Amy DuRoss
    • Co-Founder & CEO
    • Vineti
    • Mike Ellis, RPh
    • Chief Executive Officer
    • Maxor National Pharmacy Services
    • Richard Evans, DVM
    • Co-Founder/Head of Healthcare Practice
    • SSR Health, LLC
    • Matt Farber, MS
    • Senior Director
    • Walgreens
    • Brenton Fargnoli, MD
    • Director, Product Marketing & Strategy/ Medical Director, Value-Based Care
    • Flatiron Health
    • Jonathan Fassberg
    • Chief Executive Officer
    • Solebury Trout
    • A. Mark Fendrick, MD
    • Director
    • University of Michigan Center of Value-Based Insurance Design
    • Christine Ferro, CHFP
    • Healthcare Analytics Consultant
    • Milliman
    • Anthony Fiori
    • Managing Director
    • Manatt Health
    • C. Lyn Fitzgerald
    • SVP, US & Global Development
    • National Comprehensive Cancer Network
    • Michael Fitzgibbons
    • Chief Executive Officer
    • Claritas Rx
    • William Flood, MD, MSc
    • Chief Medical Officer
    • Eviti NantHealth
    • Liz Fowler, PhD
    • VP, Global Health Policy
    • Johnson & Johnson
    • John Fox, MD, MHA
    • Senior Medical Director/VP, Medical Affairs
    • Priority Health
    • Kelly Franchetti, RN, CCRN, CEN
    • VP, Global Patient Insights & Engagement
    • Mapi Group
    • Bedrick Gadea, PhD
    • Managing Partner
    • The Dedham Group
    • Rowdy Gaines
    • Olympic Hall of Fame Member
    • NBC Sports
    • Jude Gallagher
    • Director, Complex Care Clinical Strategy
    • Humana
    • Lisa Gill
    • Managing Director, Equity Research
    • JP Morgan
    • Robert Goldberg, PhD
    • Co-Founder & President
    • Center for Medicine in the Public Interest
    • Patricia Goldsmith
    • Chief Executive Officer
    • CancerCare
    • Scott Gottlieb, MD
    • Commissioner
    • Food and Drug Administration
    • Bruce Gould, MD
    • President
    • Community Oncology Alliance
    • J. Lance Grady
    • Vice President/Team Lead,
    • Market Access & Reimbursement
    • Avalere Health
    • Robert Green, MD
    • SVP, Clinical Oncology
    • Flatiron Health
    • Lindsay Greenleaf
    • Director
    • ADVI Health LLC
    • Melinda Haren, RN
    • Senior Director of Access Strategies
    • Zitter Health Insights
    • Lisa Harrison, RPh
    • Senior Director, Pharmacy Services
    • ION Solutions
    • Edward Hensley
    • Chief Commercial Officer & Co-Founder
    • AssistRx
    • Tara Herington
    • Vice President
    • Cardinal Health Specialty Solutions
    • Jennifer Hinkel, MPH
    • Partner
    • McGivney Global Advisors
    • Brad Hirsch, MD
    • Chief Executive Officer
    • SignalPath Research
    • David Hom, MBA
    • Chief Evangelist
    • SCIO Health Analytics
    • Axel Hoos, MD, PhD
    • SVP, Therapeutic Area Head, Oncology R&D
    • GlaxoSmithKline
    • Kevin Host, PharmD
    • President & COO
    • Pharmaceutical Strategies Group
    • Linda House, BSN, MSN
    • President
    • Cancer Support Community
    • Clifford Hudis, MD, FACP, FASCO
    • Chief Executive Officer
    • American Society of Clinical Oncology
    • Louis Jacques, MD
    • Chief Clinical Officer
    • ADVI Health LLC
    • Paul Jardina
    • President/CEO
    • Onco360® Oncology Pharmacy
    • Danelle Johnston, MSN, RN, ONN-CG, OCN
    • Chief Nursing Officer
    • Senior Director of Strategic Planning and Initiatives
    • The Lynx Group
    • Anna Kaltenboeck
    • Program Director and Senior Health Economist, Center for Health Policy & Outcomes,
    • Dept of Epidemiology & Biostatistics
    • Memorial Sloan Kettering Cancer Center
    • Steve Kelley, MBA
    • President & CEO
    • Carisma Therapeutics
    • Jim Kenney, RPh, MBA
    • Manager, Specialty & Pharmacy Contracts/President
    • Harvard Pilgrim Health/Academy of Managed Care Pharmacy
    • Daniel Klein
    • President/CEO
    • Patient Access Network Foundation
    • Ira Klein, MD, MBA, FACP
    • Senior Director, Healthcare Quality Strategy, Strategic Customer Group
    • Janssen Pharmaceuticals
    • Michael Kolodziej, MD
    • VP/Chief Innovation Officer
    • ADVI Health LLC
    • Brian Korb
    • Managing Director
    • Solebury Trout
    • Mark Kris, MD
    • Medical Oncologist, Thoracic Oncology Service
    • Department of Medicine
    • Memorial Sloan Kettering Cancer Center
    • Crystal Kuntz
    • VP, Healthcare Policy & Research
    • Biotechnology Innovation Organization (BIO)
    • Robin Leopold, MD
    • Managing Director, Human Resources
    • JPMorgan Chase & Co
    • Douglas Long
    • VP, Industry Relations
    • IQVIA
    • Ellen Lukens
    • Division Director, Ambulatory Payment Models Center for Medicare & Medicaid Innovation Centers for Medicare & Medicare Services
    • Sumner Madden
    • Senior Director, Access Services
    • AstraZeneca
    • Ash Malik
    • President, Life Sciences Division
    • Integra Connect, LLC
    • DeWayne Manning, RPh
    • Partner
    • Archbow Consulting
    • Wendy Marinkovich, BSN, MPH, RN
    • Manager, Credentialing
    • Blues Distinction BCBSA
    • Rusty Massey
    • VP, Provider Relations
    • AmerisourceBergen Specialty Group
    • US Bioservices
    • William McGivney, PhD
    • Managing Principal
    • McGivney Global Advisors
    • John McManus
    • President & Founder
    • The McManus Group
    • Geoff Meacham, PhD
    • Managing Director
    • Senior Analyst Biotech & Pharma
    • Barclays
    • Tom Michaels
    • SVP, Sales
    • Vivaleas
    • Annastasiah Mudiwa Mhaka, PhD
    • Senior Advisor
    • Adjuvant Partners
    • Rafeal Muniz, MD
    • Head, Global Medical Affairs
    • Mylan
    • Marcus Neubauer, MD
    • VP and Medical Director, Value-Based Reimbursement
    • McKesson Specialty Health
    • Brenda Nevidjon, RN, MSN, FAAN
    • Chief Executive Officer
    • Oncology Nursing Society
    • Everett Neville, RPh
    • EVP, Strategy, Supply Chain & Specialty
    • Express Scripts
    • Amy Niles, MBA
    • VP, External Relations
    • PAN Foundation
    • Kimberly Noonan, PhD
    • Founder & CSO
    • WindMil Therapeutics
    • Andrew Norden, MD, MPH, MBA
    • Chief Medical Officer
    • Cota Healthcare
    • Kavita Patel, MD, MS, FACP
    • Nonresident Fellow
    • Brookings Institution
    • Pamela Pelizzari, MPH
    • Healthcare Consultant
    • Milliman
    • Steve Peskin, MD, MBA, FACP
    • Executive Medical Director, Population Health
    • Horizon BCBS
    • Kip Piper, MA, FACHE
    • President
    • Health Results Group, LLC
    • Scooter Plowman, MD, MBA, MHSA
    • Head, Clinical Solutions
    • Proteus Digital Health, Inc
    • Bruce Pyenson, FSA, MAAA
    • Principal, Consulting Actuary
    • Milliman
    • Adesh Ramchandran
    • Chief Enterprise Operations Officer
    • Cancer Treatment Centers of America
    • Michael Reff, RPh, MBA
    • Founder & Executive Director
    • National Community Oncology Dispensing Association
    • Scott Reid, PharmD
    • President
    • eviCore Health
    • Robert Rifkin, MD, FACP
    • Medical Director, Biosimilars
    • US Oncology Network
    • Patrick Ronan
    • Chief Executive Officer
    • Greenleaf Health
    • Darin Rubin, MBA
    • CEO, Partner, & Managing Director
    • The Dedham Group
    • Morrie Ruffin
    • Managing Director
    • Adjuvant Global Advisors, LLC
    • Michael Ruiz de Somocurcio
    • VP, Payer & Provider Collaboration
    • Regional Cancer Care Associates
    • Peter Saltonstall
    • President & CEO
    • National Organization for Rare Disorders
    • Marc Samuels, JD, MPH
    • Founder & CEO
    • ADVI Health LLC
    • Chuck Saunders
    • Chief Executive Officer
    • Integra Connect
    • Dennis Scanlon, PhD
    • Distinguished Professor of Health Policy & Administration
    • Director, Center for Health Care and Policy Research
    • The Pennsylvania State University
    • Richard Schilsky, MD, FACP, FASCO, FSCT
    • SVP & CMO
    • American Society of Clinical Oncology
    • Patrick Schmidt
    • Chief Executive Officer
    • FFF Enterprises
    • Jeffrey Scott, MD
    • Chief Medical Officer
    • Integra Connect, LLC
    • Brian Seiz, PharmD
    • President
    • Accredo Specialty Pharmacy
    • Robert Shelley
    • VP, Biosimilars Account Management
    • Pfizer Biosimilars
    • John Simmons, PhD
    • Director, Translational Science & Diagnostics
    • PGDx
    • Greg Simon, JD
    • President
    • Biden Cancer Initiative
    • Surya Singh, MD
    • Corporate VP, Medical Benefit Management
    • CVS Caremark
    • Stan Skrzypczak
    • VP, Corporate Development & Reimbursement
    • Guardant Health
    • Alfred Slanetz, PhD
    • President & CEO
    • Geneius Biotechnology, Inc
    • Jayson Slotnik, JD, MPH
    • Managing Partner
    • Health Policy Strategies
    • Ipsita Smolinski, MBA, MPH
    • Managing Director
    • Capitol Street
    • David Spetzler, MS, MBA, PhD
    • President & CSO
    • Caris Life Sciences
    • Eric Sredzinski, PharmD
    • EVP, Clinical Affairs & Quality Assurance
    • Avella Specialty Pharmacy
    • Josh Stein
    • Co-Founder & CEO
    • AdhereTech
    • Charles Stevens, MBA, JD
    • VP & Global Lead, Commercialization & Communications, ICON Access; President, MediMedia & Complete Healthcare Communications
    • Tricia Strusowski, RN, MS
    • Manager
    • Oncology Solutions, LLC
    • Michael Sullivan
    • Chief Commercial Officer
    • Caris Life Sciences
    • Walt Talamonte
    • Corporate Medical Director
    • Ford Motor Company
    • Ray Tancredi, RPh, MBA, CSP
    • Divisional VP, Specialty Pharmacy Development & Brand Rx/Vaccine Purchasing
    • Walgreens
    • Kim Thiboldeaux
    • Chief Executive Officer
    • Cancer Support Community
    • Sean Tunis, MD, MSc
    • President & CEO
    • Center for Medical Technology Policy
    • Norris Turner, PharmD, PhD
    • VP, Strategic Alliances & Measure Implementation
    • Pharmacy Quality Alliance
    • Mike Valenti
    • Senior Research Consultant
    • Tech Vision, Frost & Sullivan
    • F. Randy Vogenberg, PhD, RPh, FASHP
    • Principal, Institute for Integrated Healthcare;
    • Co-Founder, National Institute of Collaborative Healthcare,
    • and Access Market Intelligence
    • Clorinda Walley
    • President
    • Good Days, Chronic Disease Fund
    • Susan Weidner
    • SVP, IntrinsiQ Specialty Solutions
    • AmerisourceBergen
    • William (Bill) Winkenwerder Jr, MD
    • Former CEO
    • Highmark BCBS
    • Jedd Wolchok, MD, PhD
    • Director, Parker Institute for Cancer Immunotherapy
    • Memorial Sloan Kettering Cancer Center
    • William Yoon
    • Executive Director & Head, US Medical Account Management & Strategic Alliances
    • Sandoz
    • Danielle Ziernicki, BS, RPh, PharmD
    • Head, Medical & Regulatory Affairs
    • The Dedham Group
    • Burt Zweigenhaft
    • Managing Partner, Upstream Partners
    • Co-Founder, AVBCC